Clinical Trials · NCT00291616
Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Seoul National University Hospital
- Enrollment
- 52
- Start date
- Dec 2005
- Locations
- 1 site, South Korea
- Primary endpoint
- HBeAg seroconversion, HBV DNA titer<20,000 IU/mL